Results 71 to 80 of about 237,025 (162)

Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer. [PDF]

Ther Adv Med Oncol
Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND.   +8 more
europepmc   +1 more source

Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis. [PDF]

Front Oncol
Cui F, Zhang Y, Liu Z, Zhou Y, Man C, Fan Y.   +5 more
europepmc   +1 more source

Additional predictive value of systemic inflammation indices beyond prostate specific antigen density for clinically significant prostate cancer. [PDF]

BMC Urol
Sulhan H, Kalyenci B.
europepmc   +1 more source

Abnormal Flagging of Prostate Specific Antigen Screening Tests: A Regression Discontinuity Design. [PDF]

J Gen Intern Med
Lewicki P, Jiang R, Radhakrishnan A, Schipper M, Morgan T, Stensland K.   +5 more
europepmc   +1 more source

Postmortem Serum Prostate-Specific Antigen as a Potential Marker for Prostatic Disease: A Forensic Exploratory Study. [PDF]

Cureus
Matsumoto S, Takasu S.
europepmc   +1 more source

Impact of Cadmium on Prostate-Specific Antigen and Endothelial Markers: A Risk for Prostatic Damage. [PDF]

Toxics
İritaş SB, Gözükara MG, Tutkun L, Özkan Vardar D, Büyükşekerci M, Abusoğlu G, Deniz S, Türksoy VA, Tutkun E.   +8 more
europepmc   +1 more source

Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer. [PDF]

Oncol Lett
Matsuyama T, Kimura M, Go M, Yamada S, Nishimura M, Murase H, Matsuyama R, Usami E.   +7 more
europepmc   +1 more source

From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging. [PDF]

Curr Urol
Flôres Soares da Silva HM, Gómez Rivas J, Mata Déniz P, Marugan MJ, González-Santander C, Fernández Montarroso L, Galante I, Moreno Sierra J.   +7 more
europepmc   +1 more source

Web-Based Personalized Machine Learning Recommendations to Enhance Shared Decision-Making in Prostate-Specific Antigen Screening: Randomized Controlled Trial. [PDF]

JMIR Aging
Lin YT, Huang YC, Liu CK, Cho HY, Chen M.   +4 more
europepmc   +1 more source

Detectable prostate-specific antigen after radiotherapy for clinically localized prostate cancer. [PDF]

Cancer
Falagario UG, Pellegrino F, Abbadi A, Björnebo L, Valdman A, Eriksson MH, Zelic R, Carrieri G, Gandaglia G, Briganti A, Montorsi F, Aly M, Palsdottir T, Eklund M, Nordström T, Grönberg H, Akre O, Wiklund P, Lantz A.   +18 more
europepmc   +1 more source